Journals / Dicle Tıp Dergisi / 2008 / Cilt: 35 - Sayı: 1

Comparison of amniotic membrane grafts and ıntraoperative mitomycin C for primary pterygium excision

Primer pterjium eksizyonunda amnion membran grefti ve intraoperatif mitomisin C yöntemlerinin karşılaştırılması

Pages
44–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although no statistical difference was observed between two groups according to complication and reccurence, amniotic membrane graft method was safer than primary pterygium excision with intraoperative Mitomycin C.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To evaluate and compare the effectiveness and safety of the human amniotic membrane graft with intraoperative application of Mitomycin C in primary pterygium surgery.
📊
Key Findings & Data:In 60 consecutive patients, 60 eyes were included in the study.
💡
Conclusion & Impact:Although no statistical difference was observed between two groups according to complication and reccurence, amniotic membrane graft method was safer than primary pterygium excision with intraoperative Mitomycin C.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

To evaluate and compare the effectiveness and safety of the human amniotic membrane graft with intraoperative application of Mitomycin C in primary pterygium surgery. In 60 consecutive patients, 60 eyes were included in the study. The patients were randomly divided into two groups, primary pterygium excision with intraoperative Mitomycin C (0.2 mg/ml) were applied to the 30 patients and amniotic membrane grafts were applied to the other 30 patients. Recurrence was detected in two patients (%6.66) who received amniotic membrane grafts, and in five patients (%16.66) who received primary pterygium excision with intraoperative Mitomycin C. No statistical difference was observed between groups according to the reccurence (p > 0.05). Suture lysis in early postoperative period was detected in one patient (%3.33) who received amniotic membrane grafts. Scleral melting was developed in one patient (%3.33) and punctate epitheliopathy was developed in one patient (%3.33) who received primary pterygium excision with intraoperative Mitomycin C. No statistical difference was observed between groups according to the complications (p > 0.05). Although no statistical difference was observed between two groups according to complication and reccurence, amniotic membrane graft method was safer than primary pterygium excision with intraoperative Mitomycin C.

Özet

Primer pterjium tedavisinde insan amnion membranı uygulanmasının etkinlik ve güvenilirliğinin, Mitomisin C uygulanması ile karşılaştırılması amaçlandı. Primer pterjium tanısı konan 60 hastanın 60 gözü çalışmaya dahil edildi. Hastalar rastgele iki gruba ayrılarak, 30 hastanın 30 gözüne, pterjium eksizyonu ile intraoperatif 0.2 mg/ml Mitomisin C uygulandı. Diğer 30 göze ise pterjium eksizyonu ve amnion membranı uygulandı. Amnion membran uygulanan grupta %6.66, Mitomisin C grubunda ise %16.66 nüks gelişti. İki grup nüks açısından karşılaştırıldığında istatiksel olarak anlamlı fark saptanmadı (p > 0.05). Komplikasyon olarak, amnion membran grubunda bir hastada (%3.33) postoperatif erken dönemde sütür açılması saptanırken, Mitomisin C grubunda bir hastada (%3.33) skleral erime, bir hastada da (%3.33) punktat epiteliyopati saptandı. Gruplar komplikasyon yönünden karşılaştırıldıklarında aralarında istatistiksel olarak anlamlı fark bulunmadı (p > 0.05). Her ne kadar iki grup arasında komplikasyon ve nüks açısından istatistiksel olarak anlamlı fark görülmese de; primer pterjium cerrahisinde amnion membran kullanımının intraoperatif Mitomisin C kullanımından daha güvenilir olduğu kanatine varıldı.

🔖

Cite This Article

BİLEK, B., KEKLİKÇİ, U., ŞAKALAR, Y. B., UNLU, M. K., ÇAÇA, İ. (2008). Comparison of amniotic membrane grafts and ıntraoperative mitomycin C for primary pterygium excision. Dicle Tıp Dergisi, Cilt: 35 - Sayı: 1, 44–49. https://ajindex.com/articles/349321

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999;10:282-288
  2. Chowers I, Pe'er J, Zamir E, Livni N, Ilsar M, Frucht-Pery J. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology. 2001;108:985-988
  3. Oldenburg JB, Garbus J, McDonnell JM, McDonnell PJ. Conjunctival pterygia. Cornea. 2000; 9: 200–204 4. Chabner BA, Ryan DP, Paz-Ares L, et al. Antineoplastic agents. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw- Hill; 2001:1431
  4. Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol 1999;83:748-752
  5. Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999;83:399-402
  6. Prabhasawat P, Barton K, Burkett G. Comparison of conjonctival autogrefts, amniotic membrane grefts and primary closure for pterygium excision. Ophthalmology 1997;104:974-985
  7. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autogreft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 1998;82:235-240
  8. Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995; 14: 473–484
  9. Kang DH, See LC, Liav SB, Tsai RTF. Amniotic membrane graft for primary pterygium comparison with conjunctival autograft and topical mitomycin C treatment. Br J Ophthalmol 2000; 84:973-978. 48 11.King JH, Joseph AC. An atlas ophthalmic surgery.3rd ed. Philadelphia: JB Lippincott, 1981:218-229. 12.Anduze AL, Merritt JC. Pterygium: clinical classification and management in Virgin Islands. Ann Ophthalmol 1985; 17:92-95. 13.Lewallen S. A randomized trial of conjunctival autografting for pterygium in the tropics. Ophthalmology 1989;96:1612-1614. 14.Fructh-Pery J, Siganos CS, Islar M. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 1996;103:674-677. 15.Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE. Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol 1996;80:288-291. 16.Jaros PA, Deluise VP. Pinguecula and pterygia. Surv Ophthalmol 1988;33:41. 17.Adamis AP, Starck T, Kenyon KR. The management of pterygium. Ophthalmol Clin North Am 1990;3:611. 18.Hueber A, Grisanti S, Diestelhorst M. Photodynamic the